David J. Horin

2016 - Array BioPharma

In 2016, David J. Horin earned a total compensation of $200K as Interim Chief Financial Officer at Array BioPharma, a 100% increase compared to previous year.

Compensation breakdown

Other$200,000
Total$200,000

Horin received $200K in other compensation, accounting for 100% of the total pay in 2016.

Rankings

In 2016, David J. Horin's compensation ranked 13,398th out of 14,075 executives tracked by ExecPay. In other words, Horin earned more than 4.8% of executives.

ClassificationRankingPercentile
All
13,398
out of 14,075
5th
Division
Manufacturing
5,238
out of 5,488
5th
Major group
Chemicals And Allied Products
1,835
out of 1,900
3rd
Industry group
Drugs
1,489
out of 1,543
4th
Industry
Pharmaceutical Preparations
1,134
out of 1,173
3rd
Source: SEC filing on September 13, 2017.

Horin's colleagues

We found five more compensation records of executives who worked with David J. Horin at Array BioPharma in 2016.

2016

Ron Squarer

Array BioPharma

Chief Executive Officer

2016

Mary Henahan

Array BioPharma

Chief Financial Officer

2016

Andrew Robbins

Array BioPharma

Chief Operating Officer

2016

Victor Sandor

Array BioPharma

Chief Medical Officer

2016

John Moore

Array BioPharma

General Counsel

You may also like